| Product Name | Selexipag-d8 |
| Product Code | DA-S025-b |
| Chemical name | Selexipag-d8 |
| Synonyms | 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide-d8; 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide-d8; Uptravi-d8; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy-1,1,2,2,3,3,4,4-d8]-N-(methylsulfonyl)-acetamide; |
| Impurity | NA |
| CAS Number | 1265295-16-6 |
| Alternate CAS # | NA |
| Molecular form | C26H24D8N4O4S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 504.67 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | stable isotopes |
| Boiling Point | NA |
| Applications | Selexipag-d8 is a labelled version of Selexipag which is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
